Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1999-4-16
pubmed:abstractText
After 2 weeks of nicorandil therapy, time to ischemia on stress testing was significantly less than on day 1 and not different from placebo. These data are consistent with attenuation of the anti-ischemic effects of this drug and suggest that the potassium channel-opening properties do not compensate for development of attenuation to the nitrate component of nicorandil.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0002-9149
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
83
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1120-4, A9
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10190531-Adrenergic beta-Antagonists, pubmed-meshheading:10190531-Adult, pubmed-meshheading:10190531-Aged, pubmed-meshheading:10190531-Angina Pectoris, pubmed-meshheading:10190531-Blood Pressure, pubmed-meshheading:10190531-Calcium Channel Blockers, pubmed-meshheading:10190531-Cross-Over Studies, pubmed-meshheading:10190531-Diltiazem, pubmed-meshheading:10190531-Double-Blind Method, pubmed-meshheading:10190531-Electrocardiography, pubmed-meshheading:10190531-Exercise Test, pubmed-meshheading:10190531-Female, pubmed-meshheading:10190531-Heart Rate, pubmed-meshheading:10190531-Humans, pubmed-meshheading:10190531-Male, pubmed-meshheading:10190531-Middle Aged, pubmed-meshheading:10190531-Myocardial Ischemia, pubmed-meshheading:10190531-Nicorandil, pubmed-meshheading:10190531-Time Factors, pubmed-meshheading:10190531-Verapamil
pubmed:year
1999
pubmed:articleTitle
Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris.
pubmed:affiliation
Department of Cardiology, Concord Repatriation General Hospital, University of Sydney, Australia.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't